What can we learn from the public's understanding of drug information and safety? A population survey

• Published in: The International journal of pharmacy practice Vol. 27; no. 1; p. 96
• Main Authors: Salgueiro, Esther, Gurruchaga, Cristina, Jimeno, Francisco J, Martínez-Múgica, Cristina, Martín Arias, Luis H, Manso, Gloria
• Format: Journal Article
• Language: English
• Published: England 01.02.2019
• Subjects: Adult; Adverse Drug Reaction Reporting Systems - statistics & numerical data; Aged; Drug Labeling; Drug-Related Side Effects and Adverse Reactions - prevention & control; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Spain; Surveys and Questionnaires - statistics & numerical data; Young Adult; Spain; consumer health information; patient medication knowledge; patient safety
• ISSN: 2042-7174
• DOI: 10.1111/ijpp.12458

The aim of our study was to analyse the perceptions of the public on medicine information and safety and on consumer reporting of suspected adverse drug reactions (ADR). A voluntary survey was conducted in a population ≥18 years of age in Asturias, a region in northern Spain. The survey was designed to be completed in a face-to-face street interview or completed independently by the public. The survey consisted of structured questions organised in four sections: (1) demographic data, (2) use of medicines, (3) reading and understanding of the patient information leaflet (PIL) and (4) awareness and perception about consumer reporting of ADR. A total of 402 surveys were given and analysed; 295 were completed independently and 107 were completed in street interviews. Of the population surveyed, 82.3% had taken some drug(s) in the previous 3 months, although only 62.4% had performed so by medical prescription. A quarter of respondents claimed that they never read the PIL of medicines, 12.7% that they sometimes read it, and 61.4% that they always read this information. A high percentage (82.8%) of respondents reported that they were not aware of consumer reporting of ADR, and 86.1% stated their agreement with this option. The public has great interest in useful information about all aspects involved in the use of medicines. This includes consumer reporting of suspected ADR, which is still unknown to many people.